105 related articles for article (PubMed ID: 6801134)
1. Regulation of macrophage-mediated suppression by purine nucleoside phosphorylase substrates.
Cohen A; Kimchi Z
J Immunol; 1982 May; 128(5):2253-7. PubMed ID: 6801134
[TBL] [Abstract][Full Text] [Related]
2. Effect of purine nucleoside phosphorylase substrates on the mitogen-induced stimulation of murine T and B spleen cells.
Martineau R; Willemot J
Immunopharmacology; 1983 Dec; 6(4):289-302. PubMed ID: 6418686
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of deoxyguanosine lymphotoxicity. Human thymocytes, but not peripheral blood lymphocytes accumulate deoxy-GTP in conditions simulating purine nucleoside phosphorylase deficiency.
Fairbanks LD; Taddeo A; Duley JA; Simmonds HA
J Immunol; 1990 Jan; 144(2):485-91. PubMed ID: 2104895
[TBL] [Abstract][Full Text] [Related]
4. The biochemistry and pharmacology of PD 116124 (8-amino-2'-nordeoxyguanosine), an inhibitor of purine nucleoside phosphorylase (PNP).
Dong MK; Scott ME; Schrier DJ; Suto MJ; Sircar JC; Black A; Chang T; Gilbertsen RB
J Pharmacol Exp Ther; 1992 Jan; 260(1):319-26. PubMed ID: 1530976
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of purine nucleosides in human and ovine lymphocytes and rat thymocytes and their influence on mitogenic stimulation.
Peters GJ; Oosterhof A; Veerkamp JH
Biochim Biophys Acta; 1983 Jan; 755(1):127-36. PubMed ID: 6402034
[TBL] [Abstract][Full Text] [Related]
6. Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction.
Gudas LJ; Ullman B; Cohen A; Martin DW
Cell; 1978 Jul; 14(3):531-8. PubMed ID: 99243
[No Abstract] [Full Text] [Related]
7. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
North ME; Newton CA; Webster AD
Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
[TBL] [Abstract][Full Text] [Related]
8. [Purine nucleoside phosphorylase (PNP)].
Sakiyama T
Nihon Rinsho; 1996 Dec; 54(12):3220-5. PubMed ID: 8976095
[TBL] [Abstract][Full Text] [Related]
9. The effect of deoxyguanosine on human lymphocyte function. I. Analysis of the interference with lymphocyte proliferation in vitro.
Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Wadman SK; Stoop JW; Zegers BJ
J Immunol; 1984 May; 132(5):2311-7. PubMed ID: 6425399
[TBL] [Abstract][Full Text] [Related]
10. Preliminary report on 8-amino-9-(2-thienylmethyl)guanine (PD 119,229), a novel and potent purine nucleoside phosphorylase inhibitor.
Gilbertsen RB; Scott ME; Dong MK; Kossarek LM; Bennett MK; Schrier DJ; Sircar JC
Agents Actions; 1987 Aug; 21(3-4):272-4. PubMed ID: 3120507
[TBL] [Abstract][Full Text] [Related]
11. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
[TBL] [Abstract][Full Text] [Related]
12. Potent orally bioavailable purine nucleoside phosphorylase inhibitor BCX-4208 induces apoptosis in B- and T-lymphocytes--a novel treatment approach for autoimmune diseases, organ transplantation and hematologic malignancies.
Bantia S; Parker C; Upshaw R; Cunningham A; Kotian P; Kilpatrick JM; Morris P; Chand P; Babu YS
Int Immunopharmacol; 2010 Jul; 10(7):784-90. PubMed ID: 20399911
[TBL] [Abstract][Full Text] [Related]
13. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.
Ochs UH; Chen SH; Ochs HD; Osborne WR; Scott CR
J Immunol; 1979 Jun; 122(6):2424-9. PubMed ID: 109531
[No Abstract] [Full Text] [Related]
14. A rat model of purine nucleoside phosphorylase deficiency.
Osborne WR; Barton RW
Immunology; 1986 Sep; 59(1):63-7. PubMed ID: 3019875
[TBL] [Abstract][Full Text] [Related]
15. Secondary loss of deoxyguanosine kinase activity in purine nucleoside phosphorylase deficient mice.
Snyder FF; Jenuth JP; Dilay JE; Fung E; Lightfoot T; Mably ER
Biochim Biophys Acta; 1994 Oct; 1227(1-2):33-40. PubMed ID: 7918681
[TBL] [Abstract][Full Text] [Related]
16. Consequences of the salvage of purine compounds on the proliferation of rat T-lymphocytes with normal or inhibited purine de novo synthesis.
Thuillier L; Perignon JL; Houllier AM; Munier A; Cartier P
Biochim Biophys Acta; 1984 Apr; 798(3):343-9. PubMed ID: 6424727
[TBL] [Abstract][Full Text] [Related]
17. Evidence for a pathway independent from 2'-deoxyguanosine and reversible by IL-2 by which purine nucleoside phosphorylase inhibitors block T-cell proliferation.
Boehncke WH; Gilbertsen RB; Hemmer J; Sterry W
Scand J Immunol; 1994 Mar; 39(3):327-32. PubMed ID: 8128192
[TBL] [Abstract][Full Text] [Related]
18. B cells as well as T cells form deoxynucleotides from either deoxyadenosine or deoxyguanosine.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Clin Exp Immunol; 1984 Apr; 56(1):39-48. PubMed ID: 6424986
[TBL] [Abstract][Full Text] [Related]
19. The effect of deoxyguanosine on human lymphocyte function. II. Analysis of the interference with B lymphocyte differentiation in vitro.
Spaapen LJ; Rijkers GT; Staal GE; Rijksen G; Duran M; Stoop JW; Zegers BJ
J Immunol; 1984 May; 132(5):2318-23. PubMed ID: 6425400
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.
Duan DS; Nagashima T; Hoshino T; Waldman F; Pawlak K; Sadee W
Biochem J; 1990 Jun; 268(3):725-31. PubMed ID: 2114100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
